Neuberger Berman Group LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$10.31 - $17.81 $606,351 - $1.05 Million	-58,812 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$11.6 - $21.67 $64,820 - $121,091	-5,588 Reduced 8.68%	58,812 $682,000
Q2 2019 Aug 13, 2019	BUY	$18.44 - $30.89 $569,796 - $954,501	30,900 Added 92.24%	64,400 $1.43 Million
Q1 2019 May 13, 2019	BUY	$16.51 - $31.1 $553,085 - $1.04 Million	33,500 New	33,500 $959,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $193M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.